BG27380A3 - Метод за получаване на еритромициламинови производни - Google Patents

Метод за получаване на еритромициламинови производни

Info

Publication number
BG27380A3
BG27380A3 BG032727A BG3272776A BG27380A3 BG 27380 A3 BG27380 A3 BG 27380A3 BG 032727 A BG032727 A BG 032727A BG 3272776 A BG3272776 A BG 3272776A BG 27380 A3 BG27380 A3 BG 27380A3
Authority
BG
Bulgaria
Prior art keywords
obtaining
erythromycylamine
derivatives
erythromycylamine derivatives
obtaining erythromycylamine
Prior art date
Application number
BG032727A
Other languages
Bulgarian (bg)
English (en)
Inventor
Roland Maier
Eberhard Woitun
Bernd Wetzel
Wolfgang Reuter
Hanns Goeth
Uwe Lechner
Original Assignee
Неизвестен
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25768725&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BG27380(A3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from DE2515075A external-priority patent/DE2515075C2/de
Priority claimed from DE19762606030 external-priority patent/DE2606030A1/de
Application filed by Неизвестен filed Critical Неизвестен
Publication of BG27380A3 publication Critical patent/BG27380A3/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D295/145—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6558—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
    • C07F9/65586—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system at least one of the hetero rings does not contain nitrogen as ring hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
BG032727A 1975-04-07 1976-03-29 Метод за получаване на еритромициламинови производни BG27380A3 (bg)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE2515075A DE2515075C2 (de) 1975-04-07 1975-04-07 Erythromycinderivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE19762606030 DE2606030A1 (de) 1976-02-14 1976-02-14 Neue erythromycinderivate und verfahren zu ihrer herstellung

Publications (1)

Publication Number Publication Date
BG27380A3 true BG27380A3 (bg) 1979-10-12

Family

ID=25768725

Family Applications (1)

Application Number Title Priority Date Filing Date
BG032727A BG27380A3 (bg) 1975-04-07 1976-03-29 Метод за получаване на еритромициламинови производни

Country Status (29)

Country Link
US (1) US4048306A (cs)
JP (1) JPS51128991A (cs)
AT (1) AT342770B (cs)
AU (1) AU498418B2 (cs)
BG (1) BG27380A3 (cs)
CA (1) CA1060005A (cs)
CH (2) CH621800A5 (cs)
CS (1) CS196304B2 (cs)
DD (1) DD125218A5 (cs)
DK (1) DK138656C (cs)
ES (2) ES446737A1 (cs)
FI (1) FI63244C (cs)
FR (1) FR2306703A1 (cs)
GB (1) GB1520963A (cs)
GR (1) GR60374B (cs)
HU (1) HU175186B (cs)
IE (1) IE43598B1 (cs)
IL (1) IL49359A (cs)
LU (2) LU88563I2 (cs)
MX (1) MX3277E (cs)
NL (1) NL180107C (cs)
NO (1) NO141411C (cs)
NZ (1) NZ180529A (cs)
PL (1) PL101880B1 (cs)
PT (1) PT64977B (cs)
RO (1) RO68441B (cs)
SE (1) SE425566B (cs)
SU (1) SU682134A3 (cs)
YU (1) YU87676A (cs)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4847242A (en) 1985-03-12 1989-07-11 Beecham Group P.L.C. 11-ether derivatives of erythromycins
DE3524572A1 (de) * 1985-07-10 1987-01-15 Thomae Gmbh Dr K Feste arzneimittelformen zur peroralen anwendung enthaltend 9-deoxo-11-deoxy-9,11-(imino(2-(2-methoxyethoxy)ethyliden)-oxy)-(9s)-erythromycin und verfahren zu ihrer herstellung
US5110800A (en) * 1986-02-18 1992-05-05 Eli Lilly And Company Derivatives of erythromycylamine
US4945080A (en) * 1987-05-26 1990-07-31 Eli Lilly And Company Dirithromycin metabolite
US5075289A (en) * 1988-06-07 1991-12-24 Abbott Laboratories 9-r-azacyclic erythromycin antibiotics
KR0166096B1 (ko) * 1990-11-28 1999-01-15 우에하라 아키라 6-0-메틸에리쓰로마이신 a 유도체
ZA922776B (en) * 1991-04-29 1993-10-15 Lilly Co Eli Pharmaceutical compounds
US5556839A (en) * 1991-04-29 1996-09-17 Eli Lilly And Company Form II Dirithromycin
IL103276A (en) * 1991-09-30 1997-06-10 Lilly Co Eli One-step process for production of dirithromycin
US5527780A (en) * 1992-11-05 1996-06-18 Roussel Uclaf Erythromycin derivatives
DE4410637C1 (de) * 1994-03-26 1995-09-21 Boehringer Ingelheim Vetmed Injizierbare Lösungen von Dirithromycin
FR2718450B1 (fr) * 1994-04-08 1997-01-10 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
FR2719587B1 (fr) * 1994-05-03 1996-07-12 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
AU9645998A (en) * 1997-10-29 1999-05-17 Taisho Pharmaceutical Co., Ltd. Erythromycin a derivatives
US6544555B2 (en) 2000-02-24 2003-04-08 Advancis Pharmaceutical Corp. Antibiotic product, use and formulation thereof
US6565882B2 (en) 2000-02-24 2003-05-20 Advancis Pharmaceutical Corp Antibiotic composition with inhibitor
US6541014B2 (en) 2000-10-13 2003-04-01 Advancis Pharmaceutical Corp. Antiviral product, use and formulation thereof
US20020068078A1 (en) 2000-10-13 2002-06-06 Rudnic Edward M. Antifungal product, use and formulation thereof
US6436906B1 (en) 2001-04-02 2002-08-20 Enanta Pharmaceuticals, Inc. 9-amino-14-membered macrolides derived from leucomycins
CA2533178C (en) 2003-07-21 2014-03-11 Advancis Pharmaceutical Corporation Antibiotic product, use and formulation thereof
EP1648418A4 (en) 2003-07-21 2011-11-16 Middlebrook Pharmaceuticals Inc ANTIBIOTIC PRODUCT, ITS USE AND FORMULATION
JP2006528190A (ja) 2003-07-21 2006-12-14 アドバンシス ファーマスーティカル コーポレイション 抗生物質製剤、その使用法及び作成方法
AU2004264939A1 (en) 2003-08-11 2005-02-24 Middlebrook Pharmaceuticals, Inc. Robust pellet
AU2004264356B2 (en) 2003-08-12 2011-01-27 Shionogi, Inc. Antibiotic product, use and formulation thereof
JP5686494B2 (ja) * 2003-08-29 2015-03-18 シオノギ インコーポレイテッド 抗生物質製剤、その使用法及び作成方法
EP1663169A4 (en) 2003-09-15 2010-11-24 Middlebrook Pharmaceuticals In ANTIBIOTICS, ITS USE AND FORMULATION
CA2572292A1 (en) 2004-07-02 2006-02-09 Advancis Pharmaceutical Corporation Tablet for pulsed delivery
US8778924B2 (en) 2006-12-04 2014-07-15 Shionogi Inc. Modified release amoxicillin products
US8357394B2 (en) 2005-12-08 2013-01-22 Shionogi Inc. Compositions and methods for improved efficacy of penicillin-type antibiotics
US8299052B2 (en) * 2006-05-05 2012-10-30 Shionogi Inc. Pharmaceutical compositions and methods for improved bacterial eradication

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3660376A (en) * 1970-09-30 1972-05-02 Lilly Co Eli N-arylidene erythromycylamines

Also Published As

Publication number Publication date
FI63244B (fi) 1983-01-31
NO141411B (no) 1979-11-26
IE43598L (en) 1976-10-07
NL7603569A (nl) 1976-10-11
PT64977A (de) 1976-05-01
JPS62158B2 (cs) 1987-01-06
SU682134A3 (ru) 1979-08-25
MX3277E (es) 1980-08-15
NZ180529A (en) 1978-09-20
FR2306703A1 (fr) 1976-11-05
NL180107C (nl) 1987-01-02
CH624413A5 (cs) 1981-07-31
IL49359A (en) 1979-07-25
FR2306703B1 (cs) 1979-10-12
YU87676A (en) 1982-08-31
IL49359A0 (en) 1976-06-30
SE7604052L (sv) 1976-10-08
AT342770B (de) 1978-04-25
CH621800A5 (cs) 1981-02-27
NO141411C (no) 1980-03-05
CS196304B2 (en) 1980-03-31
JPS51128991A (en) 1976-11-10
CA1060005A (en) 1979-08-07
ATA149976A (de) 1977-08-15
NL180107B (nl) 1986-08-01
LU88563I2 (fr) 1995-03-21
AU498418B2 (en) 1979-03-15
AU1272276A (en) 1977-10-13
DD125218A5 (de) 1977-04-06
GB1520963A (en) 1978-08-09
NO761172L (cs) 1976-10-08
US4048306A (en) 1977-09-13
DK145276A (da) 1976-10-08
HU175186B (hu) 1980-05-28
PT64977B (de) 1978-04-03
SE425566B (sv) 1982-10-11
PL101880B1 (pl) 1979-02-28
DK138656C (da) 1979-04-02
ES446737A1 (es) 1977-10-16
FI760845A7 (cs) 1976-10-08
GR60374B (en) 1978-05-23
IE43598B1 (en) 1981-04-08
DK138656B (da) 1978-10-09
FI63244C (fi) 1983-05-10
ES456567A1 (es) 1978-03-01
RO68441A (ro) 1983-04-29
LU74702A1 (cs) 1977-06-03
RO68441B (ro) 1983-04-30

Similar Documents

Publication Publication Date Title
BG27380A3 (bg) Метод за получаване на еритромициламинови производни
BG25093A3 (bg) Метод за получаване на хиназолонови производни
DK115376A (da) Kinolonderivater
BG27362A3 (bg) Метод за получаване на n-фенил-n-бензоил-карбамиди
BG27744A3 (bg) Метод за получаване на ханазолинови производни
BG26515A3 (bg) Метод за получаване на ациламинопроизводни
BG26518A3 (bg) Метод за получаване на производни на фенил-алкан
SE7601274L (sv) Isoxazolylbensamid-derivat
BG25517A3 (bg) Метод за получаване на имидазолови производни
BG25224A3 (bg) Метод за получаване на заместени пиримидони
BG24808A3 (bg) Метод за получаване на бензизитиазолони
BG25074A3 (bg) Метод за получаване на заместени перхалоалкиламидини
BG27368A3 (bg) Метод за получаване на субституирани пиридини
BG24799A3 (bg) Метод за получаване на бензоилуреидо-дифенилетери
SE424604B (sv) Forfarande for extrahering av metaller
BG26400A3 (bg) Метод за получаване на производни на диаминоциклитоли
BG27355A3 (bg) Метод за получаване на 11-дезокси-16-арилокси-w-тетранорпростагландини
BG27359A3 (bg) Метод за получаване на ациламинови производни
TR19184A (tr) Usul
BG27543A3 (bg) Метод за получаване на n-арил-n-(1-l-4-пиперидинил)- арилацет-амиди
SE423902B (sv) Forfarande for framstellning av purinderivat
BG27360A3 (bg) Метод за получаване на бензамиди
BG24801A3 (bg) Метод за получаване наl-пироглутамилl-пролинамид
BG26535A3 (bg) Метод за получаване на индолхинолизини
BG27361A3 (bg) Метод за получаване на заместени карбамидни производни